Immune responses of poultry to Newcastle disease virus

Developmental and Comparative Immunology

Volumn 41, Issue 3, 2013, Pages 447-453

  Kapczynski, Darrell R ^a   Afonso, Claudio L ^a   Miller, Patti J ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Immunity; Newcastle disease virus; Poultry; Vaccine

Indexed keywords

GLYCOPROTEIN; NEUTRALIZING ANTIBODY; NEWCASTLE DISEASE PARAMYXOVIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ; VIRUS VACCINE;

ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; DISEASE TRANSMISSION; IMMUNE RESPONSE; INFECTION PREVENTION; INNATE IMMUNITY; MORBIDITY; MORTALITY; NEWCASTLE DISEASE; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; POULTRY; PRIORITY JOURNAL; VACCINATION; VIRUS ISOLATION; VIRUS STRAIN; VIRUS VIRULENCE;

APPLE MOSAIC VIRUS; AVES; AVULAVIRUS; GALLUS GALLUS; MONONEGAVIRALES; NEWCASTLE DISEASE VIRUS; PARAMYXOVIRIDAE; RNA VIRUSES;

IMMUNITY; NEWCASTLE DISEASE VIRUS; POULTRY; VACCINE;

ANIMALS; ANTIBODIES, VIRAL; CHICKENS; GENE EXPRESSION REGULATION; HEMAGGLUTININS, VIRAL; HOST-PATHOGEN INTERACTIONS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; POULTRY DISEASES; VACCINATION; VIRAL VACCINES; VIRULENCE;

EID: 84883054704     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dci.2013.04.012     Document Type: Article

References (100)

1. Abolnik C., Horner R.F., Maharaj R., Viljoen G.J. Characterization of a pigeon paramyxovirus (PPMV-1) isolated from chickens in South Africa. Onderstepoort J. Vet. Res. 2004, 71:157-160.
2. Ahmed K.A., Saxena V.K., Ara A., Singh K.B., Sundaresan N.R., Saxena M., Rasool T.J. Immune response to Newcastle disease virus in chicken lines divergently selected for cutaneous hypersensitivity. Int. J. Immunogenet. 2007, 34:445-455.
3. Albiston H.E., Gorrie C.J.R. Newcastle disease in Victoria. Aust. Vet. J. 1942, 18:75-79.
4. Aldous E.W., Seekings J.M., McNally A., Nili H., Fuller C.M., Irvine R.M., Alexander D.J., Brown I.H. Infection dynamics of highly pathogenic avian influenza and virulent avian paramyxovirus type 1 viruses in chickens, turkeys and ducks. Avian Pathol. 2010, 39:265-273.
5. Alexander D.J., Parsons G. Pathogenicity for chickens of avian paramyxovirus type 1 isolates obtained from pigeons in Great Britain during 1983-85. Avian Pathol. 1986, 15:487-493.
6. Alexander D.J., Senne D.A. Newcastle Disease, other avian paramyxoviruses, and pneumovirus infections. Diseases of Poultry 2008, 75-116. Iowa State University Press, Ames. twelveth ed. Y.M. Saif, A.M. Fadly, J.R. Glisson, L.R. McDougald, L.K. Nolan, D.E. Swayne (Eds.).
7. Alexander D.J., Campbell G., Manvell R.J., Collins M.S., Parsons G., McNulty M.S. Characterisation of an antigenically unusual virus responsible for two outbreaks of Newcastle disease in the Republic of Ireland in 1990. Vet. Rec. 1992, 130:65-68.
8. Alexander D.J., Aldous E.W., Fuller C.M. The long view: a selective review of 40years of Newcastle disease research. Avian Pathol 2012, 41:329-335.
9. Al-Garib S.O., Gielkens A.L.J., Gruys E., Hartog L., Koch G. Immunoglobulin class distribution of systemic and mucosal antibody responses to Newcastle disease in chickens. Avian Dis. 2003, 47:32-40.
10. Al-Garib S.O., Gielkens A.L.J., Gruys E., Koch G. Review of Newcastle disease virus with particular references to immunity and vaccination. World Poultry Sci. J. 2003, 59:185-200.
11. Allan W.H., Lancaster J.E., Toth B. Newcastle disease vaccines their production and use. FAO Animal Production and Health Series No.10 1978, Food and Agriculture Organization of the United Nations, Rome.
12. Anonymous, 2010. USDA approves Innovax-ND vaccine for chickens. WWW.WorldPoultry.net. Available at: Nov 3, 2010.
13. Anonymous, 2011. World Livestock Disease Atlas: A Quantitative Analysis of Global Animal Health Data A (2006-2009). In: The International Bank for Reconstruction and Development - The World Bank and The TAFS Forum, (Ed.), Washington, DC.
14. Bensink Z., Spradbrow P. Newcastle disease virus strain I2 - a prospective thermostable vaccine for use in developing countries. Vet. Microbiol. 1999, 68:131-139.
15. Bwala D.G., Clift S., Duncan N.M., Bisschop S.P., Oludayo F.F. Determination of the distribution of lentogenic vaccine and virulent Newcastle disease virus antigen in the oviduct of SPF and commercial hen using immunohistochemistry. Res. Vet. Sci. 2012, 93:520-528.
16. Cannon M.J., Russell P.H. Secondary in vitro stimulation of specific cytotoxic cells to Newcastle disease virus in chickens. Avian Pathol. 1986, 15:731-740.
17. Cattoli G., Susta L., Terregino C., Brown C. Newcastle disease: a review of field recognition and current methods of laboratory detection. J. Vet. Diagn. Invest. 2011, 23:637-656.
18. Chimeno Zoth S., Gomez E., Carrillo E., Berinstein A. Locally produced mucosal IgG in chickens immunized with conventional vaccines for Newcastle disease virus. Braz. J Med. Biol. Res. 2008, 41:318-323.
19. Cho S.H., Kwon H.J., Kim T.E., Kim J.H., Yoo H.S., Park M.H., Park Y.H., Kim S.J. Characterization of a recombinant Newcastle disease vaccine strain. Clin. Vaccine Immunol. 2008, 15:1572-1579.
20. Cole R.K., Hutt F.B. Genetic differences in resistance to Newcastle disease. Avian Dis. 1961, 5:205-214.
21. Cornax I., Miller P.J., Afonso C.L. Characterization of live LaSota vaccine strain-induced protection in chickens upon early challenge with a virulent Newcastle disease virus of heterologous genotype. Avian Dis. 2012, 56:464-470.
22. Courtney S.C., Susta L., Gomez D., Hines N., Pearson J.E., Brown C.C., Miller P.J., Afonso C.L. Highly divergent virulent isolates of Newcastle disease virus from the Dominican Republic are members of a new genotype that may have evolved unnoticed for over two decades. J. Clin. Microbiol. 2012, 51:508-517.
23. Czegledi A., Ujvari D., Somogyi E., Wehmann E., Werner O., Lomniczi B. Third genome size category of avian paramyxovirus serotype 1 (Newcastle disease virus) and evolutionary implications. Virus Res. 2006, 120:36-48.
24. Degefa T., Dadi L., Yami A., Mariam G, Nassir M. Technical and economic evaluation of different methods of Newcastle disease vaccine administration. J. Vet. Med. A Physiol. Pathol. Clin. Med. 2004, 51:365-369.
25. Diel D.G., da Silva L.H., Liu H., Wang Z., Miller P.J., Afonso C.L. Genetic diversity of avian paramyxovirus type 1: proposal for a unified nomenclature and classification system of Newcastle disease virus genotypes. Infect. Genet. Evol. 2012, 12:1770-1779.
26. Diel D.G., Miller P.J., Wolf P.C., Mickley R.M., Musante A.R., Emanueli D.C., Shively K.J., Pedersen K., Afonso C.L. Characterization of Newcastle disease viruses isolated from cormorant and gull species in the United States in 2010. Avian Dis. 2012, 56:128-133.
27. Dilaveris D., Chen C., Kaiser P., Russell P.H. The safety and immunogenicity of an in ovo vaccine against Newcastle disease virus differ between two lines of chicken. Vaccine 2007, 25:3792-3799.
28. Dortmans J.C., Peeters B.P., Koch G. Newcastle disease virus outbreaks: vaccine mismatch or inadequate application?. Vet. Microbiol. 2012, 160:17-22.
29. Ghumman J.S., Wiggins A.D., Bankowski R.A. Antibody response and resistance of turkeys to Newcastle disease vaccine strain LaSota. Avian Dis. 1976, 20:1-8.
30. Giambrone J.J., Closser J. Effect of breeder vaccination on immunization of progeny against Newcastle disease. Avian Dis. 1990, 34:114-119.
31. Goldhaft T.M. Historical note on the origin of the La Sota strain if Newcastle disease virus. Avian Dis. 1980, 24:297-301.
32. Gordon C.D., Beard C.W., Hopkins S.R., Siegel H.S. Chick mortality as a criterion for selection toward resistance. Poult. Sci. 1971, 50:783-789.
33. Gould A.R., Kattenbelt J.A., Selleck P., Hansson E., Della-Porta A., Westbury H.A. Virulent Newcastle disease in Australia: molecular epidemiological analysis of viruses isolated prior to and during the outbreaks of 1998-2000. Virus Res. 2001, 77:51-60.
34. Hamal K.R., Burgess S.C., Pevzner I.Y., Erf G.F. Maternal antibody transfer from dams to their egg yolks, egg whites, and chicks in meat lines of chickens. Poult. Sci. 2006, 85:1364-1372.
35. Harrison J.L., Alders R.G. An assessment of chicken husbandry including Newcastle disease control in rural areas of Chibuto, Mozambique. Trop. Anim. Health Prod. 2010, 42:729-736.
36. Hassan M.K., Afify M.A., Aly M.M. Genetic resistance of Egyptian chickens to infectious Bursal disease and Newcastle disease. Trop. Anim. Health Prod. 2004, 36:1-9.
37. Hilton L.S., Bean A.G.D., Lowenthal J.W. The emerging role of avian cytokines as immunotherapeutics and vaccine adjuvants. Vet. Immunol. Immunopathol. 2002, 85:119-128.
38. Hoss A., Zwarthoff E.C., Zawatzky R. Differential expression of interferon alpha and beta induced with Newcastle disease virus in mouse macrophage cultures. J. Gen. Virol. 1989, 70(Pt 3):575-589.
39. Huang X., Hu Y., Zhao X., Lu Y., Wang J., Zhang F., Sun J. Sulfated modification can enhance the adjuvant activity of astragalus polysaccharide for ND vaccine. Carbohydr. Polym. 2008, 73:303-308.
40. Illango J., Olaho-Mukani W., Mukiibi-Muka G., Abila P.P., Etoori A. Immunogenicity of a locally produced Newcastle disease I-2 thermostable vaccine in chickens in Uganda. Trop. Anim. Health Prod. 2005, 37:25-31.
41. Jeurissen S.H.M., Boonstra-Blom A.G., Al-Garib S.O., Hartog L., Koch G. Defence mechanisms gainst viral infection in poultry: a review. Vet. Q. 2000, 22:204-208.
42. Kaleta E.F., Baldauf C. Newcastle disease in free-living and pet birds. Newcastle Disease 1988, 197-246. Kluwer Academic Publishers, Dordrecht, Netherlands; Boston, Massachusetts, USA. D.J. Alexander (Ed.).
43. Kaleta E.F., Kummerfeld N. Isolation of herpesvirus and Newcastle disease virus from White Storks (Ciconia ciconia) maintained at four rehabilitation centres in northern Germany during 1983 to 2001 and failure to detect antibodies against avian influenza A viruses of subtypes H5 and H7 in these birds. Avian Pathol. 2012, 41:383-389.
44. Kapczynski D.R., King D.J. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak. Vaccine 2005, 23:3424-3433.
45. Kapczynski D.R., Wise M.G., King D.J. Susceptibility and protection of naive and vaccinated racing pigeons (Columbia livia) against exotic Newcastle disease virus from the California 2002-2003 outbreak. Avian Dis. 2006, 50:336-341.
46. Kapczynski D.R., Martin A., Haddad E.E., King D.J. Protection from clinical disease against three highly virulent strains of Newcastle disease virus after in ovo application of an antibody-antigen complex vaccine in maternal antibody-positive chickens. Avian Dis. 2012, 56:555-560.
47. Khalifeh M.S., Amawi M.M., Abu-Basha E.A., Yonis I.B. Assessment of humoral and cellular-mediated immune response in chickens treated with tilmicosin, florfenicol, or enrofloxacin at the time of Newcastle disease vaccination. Poult. Sci. 2009, 88:2118-2124.
48. Kim L.M., King D.J., Guzman H., Tesh R.B., Travassos da Rosa A.P., Bueno R., Dennett J.A., Afonso C.L. Biological and phylogenetic characterization of pigeon paramyxovirus serotype-1 circulating in wild North American pigeons and doves. J. Clin. Microbiol. 2008, 46:3303-3310.
49. King D.J. Influence of chicken breed on pathogenicity evaluation of velogenic neurotropic Newcastle disease virus isolates from cormorants and turkeys. Avian Dis. 1996, 40:210-217.
50. Koppad S., Raj G.D., Gopinath V.P., Kirubaharan J.J., Thangavelu A., Thiagarajan V. Calcium phosphate coupled Newcastle disease vaccine elicits humoral and cell mediated immune responses in chickens. Res. Vet. Sci. 2011, 91:384-390.
51. Lam K.M., Kabbur M.B., Eiserich J.P. Newcastle disease virus-induced functional impairments and biochemical changes in chicken heterophils. Vet. Immunol. Immunopathol. 1996, 53:313-327.
52. Lambrecht B., Gonze M., Meulemans G., van den Berg T.P. Assessment of the cell-mediated immune response in chickens by detection of chicken interferon-gamma in response to mitogen and recall Newcastle disease viral antigen stimulation. Avian Pathol. 2004, 33:343-350.
53. Lwelamira J., Kifaro G.C., Gwakisa P.S. Genetic parameters for body weights, egg traits and antibody response against Newcastle disease virus (NDV) vaccine among two Tanzania chicken ecotypes. Trop. Anim. Health Prod. 2009, 41:51-59. Epub 2008 March 2027.
54. Marangon S., Busani L. The use of vaccination in poultry production. Rev. Sci. Tech. Off. Int. Epiz. 2006, 26:265-274.
55. Marino O.C., Hanson R.P. Cellular and humoral response of in ovo-bursectomized chickens to experimental challenge with velogenic Newcastle disease virus. Avian Dis. 1987, 31:293-301.
56. Merino R., Villegas H., Quintana J.A., Calderon N. Characterization of Newcastle disease viruses isolated from chicken, gamefowl, pigeon and quail in Mexico. Vet. Res. Commun. 2009, 33:1023-1030.
57. Merz D.C., Scheid A., Choppin P.W. Immunological studies of the functions of paramyxovirus glycoproteins. Virology 1981, 109:94-105.
58. Miller P.J., King D.J., Afonso C.L., Suarez D.L. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge. Vaccine 2007, 25:7238-7246.
59. Miller P.J., Estevez C., Yu Q., Suarez D.L., King D.J. Comparison of viral shedding following vaccination with inactivated and live Newcastle disease vaccines formulated with wild-type and recombinant viruses. Avian Dis. 2009, 53:39-49.
60. Miller P.J., Decanini E.L., Afonso C.L. Newcastle disease: evolution of genotypes and the related diagnostic challenges. Infect. Genet. Evol. 2010, 10:26-35.
61. Miller, P.J., Killian, M.L., Pederson, J.C., Afonso, C.L., 2011. Avian paramyxovirus serotype 1 strains of low virulence with unusual fusion protein cleavage sites isolated from poultry species. In: American Association of Avian Pathologists. American Veterinary Medical Association. AAAP, St. Louis, MO, p. 14.
62. Mitchell C.A., Walker R.V.L. Studies in Newcastle disease: II. Inactiated virus and adjuvant used as vaccine. Can. J. Comp. Med. Vet. Sci. 1951, 15:219-222.
63. Munir S., Sharma J.M., Kapur V. Transcriptional response of avian cells to infection with Newcastle disease virus. Virus Res. 2005, 107:103-108.
64. Munir K., Muneer M.A., Tiwari A., Chaudhry R.M., Muruganandan S. Effects of polyether ionophores on the protective immune responses of broiler chickens against Angara disease and Newcastle disease viruses. Vet. Res. Commun. 2007, 31:909-929.
65. Nasser M., Lohr J.E., Mebratu G.Y., Zessin K.H., Baumann M.P.O., Ademe Z. Oral Newcastle disease vaccination trials in Ethiopia. Avian Pathol. 2000, 29:27-34.
66. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals: Mammals, Birds and Bees, Biological Standards Commission 2012, OIE, World Organization for Animal Health, Paris, pp. 1-19.
67. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327:524-526.
68. Palya V., Kiss I., Tatar-Kis T., Mato T., Felfoldi B., Gardin Y. Advancement in vacination against Newcastle disease: recombinat HVT NDV provides high clinical protection and reduction challenge virus shedding, with the absence of vaccine reaction. Avian Dis. 2012, 56:282-287.
69. Pchelkina I.P., Manin T.B., Kolosov S.N., Starov S.K., Andriyasov A.V., Chvala I.A., Drygin V.V., Yu Q., Miller P.J., Suarez D.L. Characteristics of pigeon paramyxovirus serotype-1 isolates (PPMV-1) from the Russian Federation from 2001 to 2009. Avian Dis. 2013, 57:2-7.
70. Pearson J.E., Senne D.A., Alexander D.J., Taylor W.D., Peterson L.A., Russell P.H. Characterization of Newcastle disease virus (Avian paramyxovirus-1) isolated from pigeons. Avian Dis. 1987, 31:105-111.
71. Perey D.Y., Cleland G.B., Dent P.B. Newcastle disease in normal and immunodeficient chickens. Am. J. Vet. Res. 1975, 36:513-517.
72. Perozo F., Marcano R., Afonso C.L. Biological and phylogenetic characterization of a genotype VII Newcastle disease virus from Venezuela: efficacy of field vaccination. J. Clin. Microbiol. 2012, 50:1204-1208.
73. Ramp K., Topfstedt E., Wackerlin R., Hoper D., Ziller M., Mettenleiter T.C., Grund C., Romer-Oberdorfer A. Pathogenicity and immunogenicity of different recombinant Newcastle disease virus clone 30 variants after in ovo vaccination. Avian Dis. 2012, 56:208-217.
74. Rauw F., Gardin Y., Palya V., van Borm S., Gonze M., Lemaire S., van den Berg T., Lambrecht B. Humoral, cell-mediated and mucosal immunity induced by oculo-nasal vaccination of one-day-old SPF and conventional layer chicks with two different live Newcastle disease vaccines. Vaccine 2009, 27:3631-3642.
75. Rauw F., Gardin Y., Palya V., Anbari S., Lemaire S., Boschmans M., van den Berg T., Lambrecht B. Improved vaccination against Newcastle disease by an in ovo recombinant HVT-ND combined with an adjuvanted live vaccine at day-old. Vaccine 2010, 28:823-833.
76. Reynolds D.L., Maraqa A.D. Protective immunity against Newcastle disease: the role of cell-mediated immunity. Avian Dis. 2000, 44:145-154.
77. Rue C.A., Susta L., Cornax I., Brown C.C., Kapczynski D.R., Suarez D.L., King D.J., Miller P.J., Afonso C.L. Virulent Newcastle disease virus elicits a strong innate immune response in chickens. J. Gen. Virol. 2011, 92:931-939.
78. Russell P.H., Dwivedi P.N., Davison T.F. The effects of cyclosporin A and cyclophosphamide on the populations of B and T cells and virus in the Harderian gland of chickens vaccinated with the Hitchner B1 strain of Newcastle disease virus. Vet. Immunol. Immunopathol. 1997, 60:171-185.
79. Seal B.S., King D.J., Sellers H.S. The avian response to Newcastle disease virus. Dev. Comp. Immunol. 2000, 24:257-268.
80. Senne D.A., King D.J., Kapczynski D.R. Control of Newcastle disease by vaccination. Dev. Biol. 2004, 119:165-170.
81. Sharma J.M. Introduction to poultry vaccines and immunity. Adv. Vet. Med. 1999, 41:481-494.
82. Sharma J.M., Zhang Y., Jensen D., Rautenschlein S., Yeh H.Y. Field trial in commercial broilers with a multivalent in ovo vaccine comprising a mixture of live viral vaccines against Marek's disease, infectious bursal disease, Newcastle disease, and fowl pox. Avian Dis. 2002, 46:613-622.
83. Shi S.H., Huang Y., Cui S.J., Cheng L.F., Fu G.H., Li X., Chen Z., Peng C.X., Lin F., Lin J.S., Su J.L. Genomic sequence of an avian paramyxovirus type 1 strain isolated from Muscovy duck (Cairina moschata) in China. Arch. Virol. 2011, 156:405-412.
84. Sick C., Schultz U., Munster U., Meier J., Kaspers B., Staeheli P. Promoter structures and differential responses to viral and nonviral inducers of chicken type I interferon genes. J. Biol. Chem. 1998, 273:9749-9754.
85. Sick C., Schneider K., Staeheli P., Weining K.C. Novel chicken CXC and CC chemokines. Cytokine 2000, 12:181-186.
86. Sohail M.U., Ijaz A., Yousaf M.S., Ashraf K., Zaneb H., Aleem M., Rehman H. Alleviation of cyclic heat stress in broilers by dietary supplementation of mannan-oligosaccharide and Lactobacillus-based probiotic: dynamics of cortisol, thyroid hormones, cholesterol, C-reactive protein, and humoral immunity. Poult. Sci. 2010, 89:1934-1938.
87. Stone H.D., Xie Z.X. Efficacy of experimental Newcastle disease water-in-oil oil-emulsion vaccines formulated from squalane and squalene. Avian Dis. 1990, 34:979-983.
88. Tsai H.J., Saif Y.M., Nestor K.E., Emmerson D.A., Patterson R.A. Genetic variation in resistance of turkeys to experimental infection with Newcastle disease virus. Avian Dis. 1992, 36:561-565.
89. van Boven M., Bouma A., Fabri T.H.F., Katsma E., Hartog L., Koch G. Herd immunity to Newcastle disease virus in poultry by vaccination. Avian Pathol. 2008, 37:1-5.
90. Wakamatsu N., King D.J., Seal B.S., Peeters B.P., Brown C.C. The effect on pathogenesis of Newcastle disease virus LaSota strain from a mutation of the fusion cleavage site to a virulent sequence. Avian Dis. 2006, 50:483-488.
91. Wakamatsu N., King D.J., Seal B.S., Samal S.K., Brown C.C. The pathogenesis of Newcastle disease: a comparison of selected Newcastle disease virus wild-type strains and their infectious clones. Virology 2006, 353:333-343.
92. Westbury H.A., Parsons G., Allan W.H. Comparison of the immunogenicity of Newcastle disease virus strains V4, Hitchner B1 and La Sota in chickens. 2. Tests in chickens with maternal antibody to the virus. Aust. Vet. J. 1984, 61:10-13.
93. Wilden H., Schirrmacher V., Fournier P. Important role of interferon regulatory factor (IRF)-3 in the interferon response of mouse macrophages upon infection by Newcastle disease virus. Int. J. Oncol. 2011, 39:493-504.
94. Williams C.J., Zedek A.S. Comparative field evaluations of in ovo applied technology. Poult. Sci. 2010, 89:189-193.
95. Xiao S., Nayak B., Samuel A., Paldurai A., Kanabagattebasavarajappa M., Prajitno T.Y., Bharoto E.E., Collins P.L., Samal S.K. Generation by reverse genetics of an effective, stable, live-attenuated Newcastle disease virus vaccine based on a currently circulating, highly virulent Indonesian strain. PLoS One 2012, 7:e52751.
96. Yin J., Jin H., Kang Y., Xiao C., Zhao L., Li X., Ding Z., Yang F., Zhu Q., Wang B. Efficacy of modified levamisole adjuvant on inactivated virus vaccine. Viral Immunol. 2006, 19:525-535.
97. Zawatzky R., Wurmbaeck H., Falk W., Homfeld A. Endogenous interferon specifically regulates Newcastle disease virus-induced cytokine gene expression in mouse macrophages. J. Virol. 1991, 65:4839-4846.
98. Zhang X., Zhang X., Yang Q. Effect of compound mucosal immune adjuvant on mucosal and systemic immune responses in chicken orally vaccinated with attenuated Newcastle-disease vaccine. Vaccine 2007, 25:3254-3262.
99. Zhang Z., Sun P., Yu F., Yan L., Yuan F., Zhang W., Wang T., Wan Z., Shao Q., Li Z. Transgenic quail production by microinjection of lentiviral vector into the early embryo blood vessels. PLoS One 2012, 7:e50817.
100. Zhao X., Fan Y., Wang D., Hu Y., Guo L., Ruan S., Zhang J., Yuan J. Immunological adjuvant efficacy of glycyrrhetinic acid liposome against Newcastle disease vaccine. Vaccine 2011, 29:9611-9617.